RecruitingNCT04624555

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors


Sponsor

Case Comprehensive Cancer Center

Enrollment

50 participants

Start Date

Oct 31, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a stool DNA test (a non-invasive test that detects cancer-related DNA in a stool sample) can be used to monitor colorectal cancer survivors for signs of cancer recurrence, as an alternative or supplement to standard colonoscopy surveillance. **You may be eligible if...** - You have been diagnosed with stage I, II, or III colon or rectal cancer - You had a bowel resection (surgical removal) as part of your treatment - You had a colonoscopy before your surgery - You understand and can consent to the study in English **You may NOT be eligible if...** - You have stage IV (metastatic) colorectal cancer - You had your entire colon or rectum removed - You have inflammatory bowel disease (Crohn's or ulcerative colitis) - You have a hereditary colorectal cancer syndrome (like Lynch syndrome or familial polyposis) - You had large precancerous polyps that were not fully removed Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04624555


Related Trials